Written by Harry Wolf

Onychomycosis affects around 10 to 20 percent of the global population. It also makes up about 50 percent of all nail disorders, according to a 2025 report published by the International Journal of Advanced Biochemistry Research.

Age-related nail changes, reduced peripheral circulation, cumulative environmental exposure, and comorbid disease… They all contribute to the condition’s prevalence. 

Therapeutic decisions are rarely straightforward for clinicians. Efficacy, pathogen identification, comorbidities, drug interaction potential, laboratory monitoring requirements, adherence capacity, and cost… All influence selection between oral and topical antifungal therapies.

A Brief Overview of Onychomycosis

What exactly is onychomycosis? If you are not aware, here is the lowdown: it is a chronic fungal infection involving the nail plate, nail bed, and (in advanced cases) the nail matrix. 

Dermatophytes remain the most common etiologic agents, although non-dermatophyte molds and yeasts are increasingly identified in laboratory-confirmed cases, as detailed in an interesting analysis published by Nature’s Scientific Reports. 

Accurate organism identification has become increasingly important. Why is that? Quite simply, because therapeutic response varies by species.

Clinically, onychomycosis presents in several morphologic patterns. The following patterns influence both severity assessment and treatment selection:

• Distal lateral subungual disease with progressive onycholysis
• Superficial white onychomycosis affecting the dorsal nail plate
• Proximal subungual disease
• Total dystrophic onychomycosis in advanced and long-standing infections

Chronic fungal colonization can produce subungual hyperkeratosis, nail thickening, discoloration, and friability. Functional consequences include pain, difficulty ambulating, and impaired quality of life. 

In patients with diabetes, neuropathy, or peripheral arterial disease, thickened dystrophic nails may contribute to ulceration risk.

Diagnostic confirmation is recommended before initiating systemic therapy. 

Antifungal Therapies

Antifungal therapies for onychomycosis are categorized as systemic oral agents or topical transungual therapies. Selection should be determined by:

• Disease severity
• Nail matrix involvement
• Organism type
• Comorbidities
• Patient preference

Systemic agents achieve therapeutic concentrations in the nail bed via bloodstream distribution. 

An evidence-based review, published by the National Library of Medicine, confirms that terbinafine, itraconazole, and fluconazole demonstrate clinically meaningful efficacy in treating onychomycosis. 

Cure rates? They are generally higher with systemic therapy in moderate-to-severe disease – compared with topical monotherapy.

Topical therapies act directly at the site of infection. A study published by Springer Nature demonstrated superior transungual penetration and antifungal activity of efinaconazole compared with tavaborole, ciclopirox, and several over-the-counter options. 

Penetration capacity is clinically relevant. Why? Because the nail plate presents a dense keratin barrier.

Therapeutic strategies? They may include:

• Continuous oral dosing regimens lasting 6 to 12 weeks
• Pulse-dosed oral therapy administered in treatment cycles
• Daily topical application for 48 weeks or longer
• Combination systemic and topical approaches in refractory cases

Mechanistically, allylamines such as terbinafine inhibit squalene epoxidase. They can lead to:

• Ergosterol depletion
• Fungal cell membrane disruption

Azoles such as itraconazole inhibit lanosterol 14-alpha-demethylase, thus impairing ergosterol synthesis. And oxaboroles such as tavaborole inhibit fungal protein synthesis by targeting leucyl-tRNA synthetase.

Understanding pharmacodynamics supports rational therapeutic selection – particularly in complex or recurrent cases, that is.

Selecting Oral Antifungal Therapies

When multiple nails, matrix involvement, or extensive subungual hyperkeratosis are present, systemic therapy remains a first-line approach. Treatment selection needs a high level of attention. 

It requires careful evaluation of:

• Efficacy data
• Safety profile
• Comorbid disease
• Drug interaction potential

The Comparative Efficacy of Oral Agents

Multiple comparative trials and meta-analyses demonstrate the following. Continuous oral terbinafine produces higher mycologic and complete cure rates than intermittent itraconazole in dermatophyte toenail onychomycosis.

A double-blind randomized clinical trial, published by the Institute of Tropical Medicine, is worth noting. It compared terbinafine 250 mg daily for 12 weeks with itraconazole 200 mg daily for 12 weeks. 

The study reported significantly higher negative mycology rates at 48-week follow-ups in the terbinafine group – 73% versus  46%, in fact. Plus, there were higher rates of near-total clinical cure as well. 

These findings support continuous terbinafine as a preferred first-line agent in dermatophyte-predominant disease.

Long-term follow-up data published in JAMA Dermatology further demonstrates that terbinafine can achieve significantly higher sustained mycologic and clinical cure rates, compared with itraconazole, that is. There were lower relapses observed over extended observation periods. 

Sustained clearance is clinically meaningful. And that is because? Recurrence contributes to repeated systemic exposure and cumulative cost.

Key comparative considerations? They include:

• Higher sustained mycologic cure rates with continuous terbinafine
• Lower relapse rates in long-term follow-up with terbinafine
• Broader organism coverage with itraconazole
• Dosing flexibility with pulse itraconazole regimens

Yes, itraconazole remains an effective alternative – particularly when non-dermatophyte molds or yeasts are implicated, that is. However… continuous terbinafine therapy continues to demonstrate superior efficacy outcomes in dermatophyte-associated toenail infection.

Safety Profiles and Monitoring

Oral antifungals… They require attention to hepatic safety and drug interaction potential. A safety-focused review published by the National Library of Medicine confirms that terbinafine and itraconazole are generally well tolerated but associated with rare hepatotoxic events. 

Hepatic injury is uncommon, yes. But it is clinically significant. So, it warrants appropriate screening.

Baseline liver-function testing is widely recommended before initiating systemic therapy. Monitoring intervals vary depending on the:

• Duration of therapy
• Patient-specific risk factors

Important safety considerations include:

• CYP3A4 inhibition and interaction potential with itraconazole
• Rare hepatotoxicity associated with terbinafine
• Possible negative inotropic effects with itraconazole
• Polypharmacy concerns in older adults

Special Populations and Comorbidities

Patients with diabetes… They represent a clinically significant subgroup. Thickened, dystrophic nails may increase pressure points and contribute to ulcer risk. 

Effective fungal eradication may reduce mechanical complications in this population.

Immunocompromised patients may experience atypical or proximal subungual presentations. Broader-spectrum coverage may be considered when non-dermatophyte pathogens are suspected.

Oral therapy may be less suitable in:

• Active or chronic hepatic disease
• History of medication-induced hepatotoxicity
• Inability to adhere to monitoring protocols
• Patient preference for localized therapy

Selecting Topical Antifungal Therapies

Topical therapy… It plays a central role in mild-to-moderate onychomycosis and in patients who cannot tolerate systemic agents. Localized therapy minimizes systemic exposure. However, it requires sustained adherence and realistic counseling regarding duration.

Indications for Topical Monotherapy

Topical monotherapy is typically reserved for limited nail involvement without matrix infection. Treatment duration often approaches 48 weeks because nail growth is slow and drug penetration through keratin is limited.

Appropriate candidates may include:

• Involvement of less than 50 percent of a single nail
• Absence of matrix involvement
• Contraindications to systemic therapy
• Preference to avoid systemic adverse effects

Comparative Effectiveness of Topical Agents

Let’s now reference laboratory evidence published by Springer Nature. It demonstrated significantly greater antifungal activity and transungual penetration for efinaconazole compared with tavaborole, ciclopirox, and evaluated over-the-counter products. 

Enhanced penetration may improve mycologic clearance – in carefully selected patients, that is.

Also, the study published by the  International Journal of Advanced Biochemistry Research, which we referenced earlier, emphasizes relapse risk and identifies adherence as a primary determinant of success. 

Prolonged daily application is required. For what reason? To maintain therapeutic drug levels in the nail plate.

Prescription options include:

• Efinaconazole 
• Tavaborole 
• Ciclopirox 

Clinical selection depends on severity, penetration profile, and tolerability – as well as financial accessibility. So, if you are looking for products containing the active ingredient of efinaconazole, such as Jublia, for example, consider all those elements.

Reviewing the cost of Jublia at PricePro Pharmacy could assist patients in aligning their therapy with affordability.

Combination Therapy and Adjunctive Measures

Combination therapy may be considered in recalcitrant cases. Concomitant topical therapy during or after systemic treatment may reduce recurrence risk – by suppressing residual fungal elements, that is.

Adjunctive strategies? They include:

• Mechanical debridement to reduce nail thickness
• Regular trimming to decrease fungal burden
• Treatment of concomitant tinea pedis
• Environmental hygiene to reduce reinfection

Addressing concomitant skin infection reduces the likelihood of nail reinoculation.

Adherence 

Adherence remains a significant barrier in topical therapy. Daily application for extended periods requires sustained patient engagement.

Clinical reviews highlight:

• Nearly year-long treatment timelines
• Gradual cosmetic improvement rather than rapid change
• Higher relapse rates compared with systemic therapy

Clear communication regarding expected time frames and visible milestones is crucial. Because? It improves persistence and therapeutic satisfaction.

Evolving Dermatophyte Resistance Patterns 

Emerging antifungal resistance is increasingly influencing clinical decision-making in onychomycosis management. Clinically relevant considerations include:

• Refractory infection despite confirmed adherence
• Recurrence shortly after completing systemic therapy
• History of travel to areas with reported resistant strains
• Prior prolonged or repeated terbinafine exposure

Itraconazole is frequently utilized as an alternative systemic agent when terbinafine resistance is suspected. In documented resistant cases, switching antifungal class has demonstrated clinical improvement. 

Molecular diagnostic tools and susceptibility testing may become increasingly relevant in tertiary-care and academic settings.

Also, antifungal resistance reinforces the importance of avoiding empiric systemic therapy without laboratory confirmation. Confirmed diagnosis prior to initiation minimizes unnecessary exposure. And it may reduce selective pressure that contributes to resistance development.

Recurrence Prevention and Long-Term Management 

Recurrence remains a persistent challenge in onychomycosis management. Even after an apparent clinical cure. 

Data indicates relapse rates of approximately 20 to 25 percent within two years following successful treatment, as summarized in that study published by the International Journal of Advanced Biochemistry Research. 

For clinicians, a durable cure requires attention beyond initial fungal eradication.

According to an article by Infection and Drug Resistance, recurrence may be influenced by:

• Biofilm formation
• Untreated concomitant tinea pedis
• Persistent environmental reservoirs
• Host factors such as immunosuppression or diabetes

Addressing those elements can improve long-term outcomes. 

Preventive strategies include:

• Treating coexisting tinea pedis concurrently
• Encouraging proper foot hygiene and drying practices
• Disinfecting footwear and nail-care instruments
• Monitoring high-risk patients periodically after cure

Patients with diabetes, peripheral vascular disease, or immunosuppression may require closer follow-ups. Why is that? Quite simply, it is due to elevated complication risk. 

Maintenance topical therapy following systemic treatment has been explored as a strategy to reduce recurrence, particularly in individuals with repeated relapse.

Environmental reinoculation also plays a role in recurrence. Shared showers, occlusive footwear, and persistent fungal reservoirs in socks or shoes may facilitate reinfection. Counseling patients about these risks will help to improve long-term therapeutic durability.

Recurrence prevention represents a shift from episodic treatment toward longitudinal management. Integrating preventive counseling into routine care:

• Supports sustained remission
• Reduces cumulative treatment burden

Applying Clinical Judgment in Onychomycosis Management

Let’s recap. Firstly, effective onychomycosis management requires individualized assessment – rather than protocol-driven uniformity, that is. 

Oral antifungal therapy generally provides higher complete cure rates in moderate-to-severe disease. Topical antifungal therapy offers a valuable alternative for localized infection or when systemic agents are contraindicated.

Diagnostic confirmation, organism identification, safety monitoring, adherence counseling, and financial accessibility… They all influence therapeutic success. 

Hopefully, this article has been helpful. If it has been, take a look at our other relevant content.

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References

• Unauthored, 2022, Toenail Fungus, Cleveland Clinic.

https://my.clevelandclinic.org/health/diseases/11303-toenail-fungus

• Unauthored, 2024, Toenail fungus (onychomycosis), Harvard Health Publishing.

https://www.health.harvard.edu/a_to_z/toenail-fungus-onychomycosis-a-to-z

• Bodman, M. A., Syed, H. A., & Krishnamurthy, K., 2025, Onychomycosis, National Library of Medicine.

https://www.ncbi.nlm.nih.gov/books/NBK441853/

• Sinha, R., Rathaur, H., & Mukhopadhyay, S., 2025, Onychomycosis focus in the elderly: Prevalence, diagnosis and treatment strategies, International Journal of Advanced Biochemistry Research.

https://www.biochemjournal.com/archives/2025/vol9issue6/PartB/9-5-104-852.pdf

• Mayengo, R., Petra, N. P., Joseph, O., Ogwang, E., Kitunzi, G. M., Onguti, A. G., & Mirembe, S. K., 2025, Onychomycosis prevalence etiology and associated factors in women using nail cosmetics attending Mbarara regional referral hospital dermatology clinic Uganda, Nature.

https://www.nature.com/articles/s41598-025-30250-8

• De Sa, D. C., Lamas, A. P., & Tosti, A., 2014, Oral therapy for onychomycosis: an evidence-based review, National Library of Medicine.

https://www.ncbi.nlm.nih.gov/books/NBK189719/

• Elabbasi, A., Kadry, A., Joseph, W., Elewski, B., & Ghannoum, M., 2024, Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison, Springer Nature.

https://link.springer.com/article/10.1007/s13555-024-01237-6

• De Backer, M., De Keyser, P., De Vroey, C., & Lesaffre, E., 1996, A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day – a double-blind comparative trial, Institute of Tropical Medicine Antwerp.

https://research.itg.be/en/publications/a-12-week-treatment-for-dermatophyte-toe-onychomycosis-terbinafin/

• Sigurgeirsson, B., Ólafsson, J. H., Steinsson, J. Þ., Paul, C., Billstein, S., & Evans, E. G. V., 2001, Long-term Effectiveness of Treatment With Terbinafine vs Itraconazole in OnychomycosisA 5-Year Blinded Prospective Follow-up Study, JAMA Network.

https://jamanetwork.com/journals/jamadermatology/fullarticle/478735

• Gupta, A. K., Haas-Neill, S., & Talukder, M., 2023, The safety of oral antifungals for the treatment of onychomycosis, National Library of Medicine.

https://pubmed.ncbi.nlm.nih.gov/37925672/

• Axler, E., & Lipner, S. R., 2024, Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes, Infection and Drug Resistance.

https://www.tandfonline.com/doi/pdf/10.2147/IDR.S431526

Please also review AIHCP’s Managed Health Care Consultant Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Harry Wolf,

Plantar heel pain… When clinicians evaluate this, they rely on structured assessment methods to identify symptom patterns, determine underlying causes, and guide effective treatment. 

By combining patient history, physical examination, functional testing, and selective imaging, practitioners can accurately differentiate plantar fasciopathy from other conditions – and develop targeted management strategies.

Clinical Interviews and Patient History

A thorough clinical interview is one of the most efficient ways in which clinicians begin evaluating a patient’s plantar pain. It is foundational to building a clear diagnostic pathway. 

This step allows clinicians to collect information that reveals:

• Symptom characteristics.
• Functional limitations.
• Potential contributing factors. 

In settings that prioritize accuracy and efficiency, gathering patient history early on ensures that later assessments are targeted and relevant. Thus, the need for unnecessary testing or redundant procedures is reduced.

Asking Questions

Clinicians typically begin by having the patient describe the onset and progression of their heel pain. 

(As you may know: plantar fasciopathy commonly develops gradually.) 

Many patients report that their symptoms began after an increase in:

• Standing time.
• Walking distance.
• Repetitive impact activities. 

Understanding whether the symptoms emerged suddenly or progressively helps clinicians distinguish between soft tissue irritation, structural injury, and conditions that may have systemic origins. 

And patients are often asked to describe specific behaviors of their symptoms throughout the day. 

The classic morning pain pattern associated with plantar fasciopathy is an important diagnostic clue. And identifying whether symptoms improve with initial movement offers additional clinical value.

Another key line of questioning focuses on occupational and lifestyle factors. 

Individuals who stand on hard surfaces for extended periods – such as food service workers or manufacturing employees – tend to experience increased mechanical stress on the plantar fascia. 

Similarly, athletes who abruptly change their training volume – or footwear – may develop symptoms that are related to overload. 

By clarifying such details, clinicians can determine whether daily load patterns are consistent with typical presentations of plantar heel pain.

Looking at Medical History

Clinicians also review the patient’s medical history – to assess whether underlying health conditions could contribute to symptom development or delayed tissue healing. 

Conditions such as diabetes, rheumatoid arthritis, thyroid dysfunction, or chronic obesity can influence how tissues respond to mechanical stress. 

Patients may also have a history of lower extremity injuries, gait alterations, or previous foot conditions that lead to compensatory movement patterns.

Noticing Red Flags

In addition to individual factors, clinicians look for red flags that require further evaluation. 

These include:

• Progressive neurologic symptoms.
• Night pain that is unrelated to activity.
• Unexplained swelling.
• Bilateral symptoms without clear mechanical triggers. 

Identifying such findings early on plays an important role in determining whether referral or additional testing is necessary.

The clinical interview gives clinicians a solid foundation to guide physical examination, functional testing, and imaging decisions.

Physical Examination and Palpation Findings

Physical examination… It is a critical step in diagnosing plantar heel pain, as it provides objective data that directly confirms or challenges the initial impressions formed during the interview. 

Efficient assessments typically begin with:

• Palpation.
• Range of motion testing.
• Observation of basic functional movements. 

Each of these components helps clinicians identify whether symptoms align with plantar fasciopathy or another condition.

Palpation of the proximal plantar fascia at the medial calcaneal tubercle is one of the most widely recognized and reliable diagnostic indicators. Patients with plantar fasciopathy typically experience sharp, localized tenderness at this point. 

The study entitled “Medical imaging for plantar heel pain: a systematic review and meta-analysis,” published by the National Library of Medicine, describes this specific palpation finding as one of the most reproducible markers for diagnosing plantar heel pain. 

By confirming localized tenderness, it becomes easy to differentiate plantar fascia involvement from nerve entrapment, fat pad disorders, or bone-related conditions.

As well as focal tenderness, clinicians evaluate soft tissue texture. They note any thickening, swelling, or irregularities along the fascia. 

These tissue changes often indicate adaptive responses to repeated mechanical stress. 

And palpation along the arch and into the midfoot can reveal whether symptoms are isolated or part of a broader mechanical pattern.

Range of motion assessment complements palpation findings and helps clinicians determine whether mechanical restrictions contribute to the patient’s symptoms. 

Visual inspection of foot posture during standing may also reveal pes planus or pes cavus tendencies – both of which influence plantar fascia loading.

In some cases, clinicians also evaluate whether patients are using external devices to support the foot. 

This may include footwear modifications or the use of medical-grade Plantar Fasciitis orthotics, which not only cushion the heel but also correct the strain on the plantar fascia band.

Medical-grade insoles address the specific biomechanical issues that cause an individual’s plantar fasciitis.

Functional Tests and Mechanical Loading Response

Functional testing provides real-time insight into how the plantar fascia responds to mechanical stress – making these tests highly valuable in an efficient diagnostic process. 

Clinicians use functional movements to determine whether symptoms are consistent with plantar fasciopathy and to assess the overall lower extremity performance. 

Functional tests not only help confirm a diagnosis. They also guide treatment planning by revealing strength deficits, mobility limitations, or altered movement patterns.

The Windlass Test

You may be aware of the windlass test. It is one of the most important and commonly used functional assessments for plantar heel pain. 

By dorsiflexing the great toe and tensioning the plantar fascia, clinicians can provoke symptoms in individuals with plantar fasciopathy. 

A positive windlass test supports the diagnosis, especially when combined with the focal tenderness identified during palpation. 

The windlass test is particularly useful when symptom reproduction is immediate and localized.

Heel Squeeze Testing

Clinicians use the heel squeeze test to rule out calcaneal stress fractures.

This involves compressing the heel medially and laterally to assess for deep bone pain. 

Stress fractures, unlike plantar fasciopathy, typically produce a sharp, deep ache when this test is performed. 

A negative heel squeeze test supports a soft tissue origin of symptoms – whilst a positive test helps clinicians determine whether imaging may be necessary.

Activity-Based Provocation Tests

Activity-based tests include heel raises, single-leg balance, and step-down movements. Each of those tests challenges the plantar fascia differently. 

Clinicians observe how the patient performs these tasks – looking for abnormal weight shifting, pain triggers, or endurance deficits. These assessments help identify whether the plantar fascia can tolerate functional loading – or whether certain movements consistently reproduce pain.

Also, clinicians often assess whether repetitive loading worsens symptoms over time. For example, performing several consecutive heel raises can reveal fatigue or compensatory mechanics that do not appear during isolated movements. 

This process helps clinicians identify whether strengthening, flexibility, or movement retraining should be prioritized when creating a treatment plan.

Integrating Functional Testing Into Diagnostic Reasoning

Functional testing enables clinicians to compare the involved foot with the contralateral limb. Differences in balance, strength, or movement quality often highlight biomechanical contributors – that are not visible during static assessments. 

These insights help determine whether plantar fasciopathy is linked to broader kinetic chain dysfunctions, such as:

• Weak hip stabilizers.
• Limited leg flexibility. 

Functional tests, therefore, enhance both diagnostic accuracy and treatment efficiency.

Imaging and Evidence-Based Diagnostics

Although plantar fasciopathy is typically diagnosed through clinical examination, imaging plays an important role – when symptoms do not improve as expected or when the diagnosis remains uncertain, that is. 

Clinicians use imaging selectively to:

• Confirm soft tissue changes.
• Identify structural abnormalities.
• Rule out alternative conditions.

Ultrasound is often the first imaging choice – due to its convenience, affordability, and ability to visualize soft tissue structures. 

Clinicians can measure plantar fascia thickness, identify hypoechoic regions, and assess the presence of perifascial fluid. 

According to a study published by the National Library of Medicine, ultrasound findings closely correlate with symptomatic presentations, making it a useful tool in confirming the diagnosis.

And radiographs can help clinicians rule out bone abnormalities. 

MRI is reserved for chronic, persistent, or complex cases that require detailed visualization of both soft tissue and bone. MRI can identify: partial tears, chronic degeneration, or bone marrow edema. 

So, these steps should be taken:

• Ultrasound.
• Radiographs.
• MRI.

Even when imaging is used, efficient clinicians rely primarily on physical examination and patient interviews to drive diagnostic decisions.

Differential Diagnosis and Condition Classification

Differential diagnosis is essential for efficiently identifying plantar fasciopathy – among the many conditions that can cause heel pain. 

Because several disorders share overlapping symptoms, clinicians systematically compare findings from the interview, physical examination, and functional testing – to distinguish between them.

Neuropathic conditions, such as Baxter’s nerve entrapment, often produce burning sensations or radiating pain that is not typical of plantar fasciopathy. 

Clinicians test for nerve tension, sensory changes, and symptom patterns unrelated to mechanical load to identify these presentations.

Mechanical conditions (such as fat pad atrophy) create diffuse heel pain that worsens on hard surfaces, contrasting with the localized tenderness characteristic of plantar fasciopathy. 

Gait observation and palpation help differentiate these conditions effectively.

Inflammatory or systemic conditions may require laboratory testing when patients have issues like bilateral heel pain or prolonged morning stiffness – or symptoms that extend beyond typical mechanical patterns. Identifying these cases early on ensures appropriate referral.

Condition Classification

Clinicians often classify plantar heel pain into phases such as:

• Acute.
• Subacute.
• Chronic. 

This classification helps guide treatment intensity and expectations for recovery. 

Acute symptoms may require load reduction and symptom management, while chronic symptoms typically benefit from progressive loading, movement retraining, or supportive strategies that address long-term biomechanical patterns.

Evidence-Supported Approaches

Research published by MDPI highlights this: clinicians using structured classification systems demonstrate greater efficiency and diagnostic confidence. 

By integrating classification into differential diagnosis, practitioners can streamline both evaluation and the planning of treatment.

The Bottom Line

Clinicians assess plantar heel pain efficiently by combining:

• Thorough patient interviews.
• Targeted palpation.
• Functional testing.
• Selective imaging. 

These strategies allow practitioners to differentiate plantar fasciopathy from other conditions, classify symptom stages, and guide evidence-based interventions. 

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References

• Mayo Clinic Staff, Plantar fasciitis, Mayo Clinic, 2023.

https://www.mayoclinic.org/diseases-conditions/plantar-fasciitis/symptoms-causes/syc-20354846

• Rodseth, Merinda, Bell, Jess, Jackson, Kim, Jaraczewska, Ewa, Ogunleye, Olajumoke, Saban, Bernice, Assessment of Plantar Heel Pain – A Literature Review, Physiopedia.

https://www.physio-pedia.com/Assessment_of_Plantar_Heel_Pain_-_A_Literature_Review

• Unauthored, How should I assess a person with suspected plantar fasciitis?, National Institute for Health and Care Excellence, 2024.

https://cks.nice.org.uk/topics/plantar-fasciitis/diagnosis/assessment/

• Nweke, Tonyclinton C., Comprehensive Review and Evidence-Based Treatment Framework for Optimizing Plantar Fasciitis Diagnosis and Management, National Library of Medicine, 2025.

https://pubmed.ncbi.nlm.nih.gov/40717873/

• Drake, Chris, Whittaker, Glen A., Kaminski, Michelle R., Chen, John, Keenan, Anne-Maree, Rathleff, Michael S., Robinson, Philip, Landorf, Karl B., Medical imaging for plantar heel pain: a systematic review and meta-analysis, National Library of Medicine, 2022.

https://pubmed.ncbi.nlm.nih.gov/35065676/

• Alnefaie, Abdulmajeed Muhaysin, Alzahrani, Hosam, Alshehri, Mansour Abdullah, Physiotherapy Management of Plantar Fasciitis: A National Cross-Sectional Survey in Saudi Arabia, MDPI, 2025.

https://www.mdpi.com/2077-0383/14/13/4584

• Akhtar, Amir, Baxter’s Nerve Entrapment, My MSK Clinic.

https://mymskclinic.co.uk/baxters-nerve-entrapment/

Please also review AIHCP’s Health Care Manager Certification program and see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Veronica Turner

People today invest a great deal of time, effort, and money in having a beautiful smile. As a result, the global dental industry is expected to reach $87.65 billion by 2032, from $37.86 billion in 2024.

But oral health is not just about pearly-white, straight teeth, and minty-fresh breath. There’s a lot more going on under the surface. Between 1913, when Alfred C. Fones opened the first dental hygiene school, and today, we’ve gathered enough data to know there is a strong connection between oral and systemic health.

A growing body of scientific literature shows that the immune system and oral health are closely interconnected. In today’s piece, we’ll analyze this connection between oral health and the immune function, what good oral health is, and the role nutrition plays.

The Connection Between Oral Health and the Immune System

The oral cavity is the entryway to our internal systems. We use it primarily for nutrient intake, but it’s also the gate for a wide range of bacteria, viruses, fungi, and foreign antigens. The mouth is one of the most heavily colonized sites in the body, right after the large intestine, and its health is critical in managing a massive microbial population.

First on the defense lines is the oral mucosa (the lining of the mouth), acting as a physical and immunological barrier. Its job is twofold as it has to limit microbial colonization and prevent penetration into deeper tissues, while also tolerating the ones that are beneficial for the gut.

Coming to its aid are the salivary glands and saliva, which contain a range of antioxidants (like uric acid and antioxidant enzymes) that protect the oral tissues from oxidative stress. Saliva continuously flushes non-adherent bacteria and food debris, while its mucins lubricate the oral mucosa, protecting it from mechanical irritation and dryness.

The oral mucosa contains immune cells, such as innate lymphoid cells. These act as a rapid defense system and modulate tolerance to the normal microbial flora. However, if oral health is compromised, such as through periodontitis (gum disease), severe decay, poor hygiene, smoking, or systemic diseases (diabetes), a breach occurs. 

This allows oral pathogens and their inflammatory byproducts (like lipopolysaccharides (LPS)) to enter the bloodstream (a process called microbial translocation or bacteremia), triggering a systemic immune response and inflammation.

This low-grade, sustained inflammation elevates systemic inflammatory markers (like IL-6 and CRP), taxing the overall immune system and setting the stage for systemic disease.

The Link with Chronic Systemic Diseases

Data shows there is a clear bidirectional connection between poor oral health and certain systemic diseases, such as cardiovascular diseases and diabetes. 

Cardiovascular Disease (CVD)

Studies consistently show that individuals with periodontitis face an increased risk of heart disease, stroke, and myocardial infarction. That’s because chronic periodontal inflammation promotes endothelial activation and atherogenesis (plaque formation in arteries), which is the central process underlying CVD.

If initiated early, periodontal treatment may reduce systemic inflammatory markers and improve vascular parameters.

Diabetes Mellitus (DM)

Periodontitis is often cited as the “sixth complication of diabetes mellitus”. This is a strong, well-studied, bidirectional association. 

DM increases the risk and severity of periodontitis by impairing blood flow, weakening the immune response, and leading to high sugar levels in saliva. Conversely, periodontitis exacerbates DM by contributing to systemic inflammation, which is directly linked to insulin resistance (a hallmark of Type 2 DM), worsening blood sugar control.

Other Associated Conditions

Scientific literature also links poor oral health to:

• Respiratory infections: Aspiration of oral bacteria into the lungs can worsen conditions like Chronic obstructive pulmonary disease (COPD) or increase the risk of pneumonia.
• Adverse pregnancy outcomes: Systemic inflammation caused by oral health diseases leads to the release of pro-inflammatory cytokines, which may affect fetal development.
• Rheumatoid Arthritis (RA): The periodontal pathogen Porphyromonas gingivalis is specifically implicated in generating peptides that may trigger RA markers.
• Neurodegenerative diseases: Oral bacteria, including P. gingivalis, have been identified in the brains of Alzheimer’s disease patients.

Oral Health Prevention and Treatment

Oral diseases are largely preventable, yet, according to the U.S. Centers for Disease Control and Prevention (CDC), tooth decay is one of the most common health conditions across the world.

Data from the World Health Organization (WHO) estimates that nearly 3.7 billion people suffer from oral diseases, which could have been prevented with good oral care. 

This is, in large part, due to a lack of access to professional dental services (in many low- and middle-income countries) or high costs. Advanced dental services can be expensive and are not typically covered by national universal health coverage (UHC) benefit packages.

The good news is that good oral hygiene habits and regular dental screenings can drastically improve oral health worldwide. 

Mechanical cleaning habits such as brushing, interdental cleaning, and tongue cleaning disrupt and remove the plaque biofilm, which is the main cause behind decay and gum disease. According to the American Dental Association, cleaning one’s teeth twice a day is optimal for reducing the risk of caries (decay) and periodontitis.

It’s important to use a fluoride toothpaste. Fluoride promotes enamel remineralization and inhibits the metabolic activity of cariogenic bacteria, helping keep teeth healthy and strong. 

The Importance of Regular Screening

Adequate oral care requires proper mechanical cleaning and regular screening. Daily mechanical cleaning helps keep bacteria in check at home, while regular dental screenings help detect and treat any underlying issues before they become a problem.

In a country like the US, where there are over 139k delta practices, getting a regular screening is not that difficult. A local practice, like this Sarasota Dentist cabinet, can see 10 to 15 patients per day, which means it can oversee regular screenings and treatments for around 1,600 patients per year. 

Dental professionals are trained to spot subtle, early indicators of disease that an individual may not notice at home. For example, some individuals have genetic, systemic, or lifestyle risk factors that can lead to periodontitis, even if they have impeccable oral hygiene. On the other hand, correct brushing can miss deep pits, grooves (fissures), or areas where teeth touch. 

Dentists also perform a thorough soft-tissue examination to look for suspicious ulcers, lumps, or discolorations that may indicate oral cancer or a pre-cancerous lesion. Early detection significantly increases survival rates.

Professional Calculus and Biofilm Management

Once a year (or more often if needed), dentists must remove calculus (hardened dental plaque) and certain biofilms from their patients’ teeth. These build up in time, no matter how diligently one brushes and flosses. If left unaddressed, they can cause additional damage. 

Calculus cannot be removed by brushing or flossing once it forms, and it creates a rough surface that allows plaque to accumulate rapidly. This is why professionals use specialized ultrasonic and hand instruments (scaling) to remove this material above and below the gumline.

In summary, regular screenings serve as an essential quality-control measure and early-warning system, providing diagnostic tools (X-rays, probes) and therapeutic services (calculus removal) that turn good home care into comprehensive preventive care.

The Role of Nutrition in Oral Health

The scientific consensus is that nutrition influences oral health, but oral health also affects the nutrients we consume. It’s a bidirectional relationship that requires a state of balance to function optimally. 

During the development phase, calcium, phosphorus, and Vitamin D are essential for proper tooth mineralization (calcification). Once permanent teeth are fully formed, the same nutritional elements are needed to support the protective layer (enamel) and maintain integrity.

Vitamins and minerals support the resilience of the gingival and mucosal tissues, influencing wound healing and immune function in the mouth: 

• Vitamin C is crucial for collagen synthesis, which forms the structural basis of healthy gingival connective tissue.
• B Vitamins (especially B12, Niacin, and Riboflavin) are essential for maintaining healthy epithelial tissues and preventing lesions like angular cheilitis or glossitis.

Furthermore, what you eat every day shapes the oral microbial environment. 

Frequent intake of sugars (sucrose, glucose, fructose) and refined starches (fermentable carbohydrates) lowers the pH in the mouth, weakening tooth enamel and creating a favorable environment for tooth decay. 

On the other hand, a diet rich in antioxidants (found in fruits, vegetables, and whole grains) is crucial for controlling oxidative stress and inflammation. Vitamins E and A, Beta-carotene, Zinc, and Selenium support the immune system’s ability to regulate inflammatory responses in the gums.

Research also suggests that increasing the intake of long-chain omega-3 fatty acids (e.g., from fish oil) may have a protective effect against periodontitis due to their known anti-inflammatory and pro-resolving effects.

When it comes to oral health, nutrition is not just about avoiding sugary foods and snacks; it is about providing the essential building blocks for repair while minimizing the fuel for pathogens.

Conclusion: Oral Health is Essential for Disease Prevention

Healthy gums and teeth maintain a protective barrier, preventing oral pathogens from entering the systemic circulation. Compromised oral health can lead to the seeding of pathogens that may aggravate conditions such as heart disease, diabetes, and more.

Good oral hygiene, regular screenings, and a healthy diet help prevent the formation of cavities (dental caries) and gum disease, which are the leading causes of acute dental pain and abscess formation. 

Author Bio: Veronica Turner is a health and lifestyle writer with over 10 years of experience. She creates compelling content on nutrition, fitness, mental health, and overall wellness.

References

Dental market size, share & growth: Industry trends [2032]. Dental Market Size, Share & Growth | Industry Trends [2032]. (n.d.). https://www.fortunebusinessinsights.com/dental-market-106251 

Centers for Disease Control and Prevention. (n.d.). About cavities (tooth decay). Centers for Disease Control and Prevention. https://www.cdc.gov/oral-health/about/cavities-tooth-decay.html 

Pelaez-Prestel, H. F., Sanchez-Trincado, J. L., Lafuente, E. M., & Reche, P. A. (2021). Immune Tolerance in the Oral Mucosa. International journal of molecular sciences, 22(22), 12149. https://doi.org/10.3390/ijms222212149 

Saini, R., Saini, S., & Sugandha, R. (2011). Periodontal disease: The sixth complication of diabetes. Journal of family & community medicine, 18(1), 31. https://doi.org/10.4103/1319-1683.78636 

Fábián, T. K., Hermann, P., Beck, A., Fejérdy, P., & Fábián, G. (2012). Salivary defense proteins: their network and role in innate and acquired oral immunity. International journal of molecular sciences, 13(4), 4295–4320. https://doi.org/10.3390/ijms13044295 

Matsuoka, M., Soria, S. A., Pires, J. R., Sant’Ana, A. C. P., & Freire, M. (2025). Natural and induced immune responses in oral cavity and saliva. BMC immunology, 26(1), 34. https://doi.org/10.1186/s12865-025-00713-8 

Bida, F. C., Curca, F. R., Lupusoru, R. V., Virvescu, D. I., Scurtu, M., Rotundu, G., Butnaru, O. M., Tudorici, T., Luchian, I., & Budala, D. G. (2025). The Systemic Link Between Oral Health and Cardiovascular Disease: Contemporary Evidence, Mechanisms, and Risk Factor Implications. Diseases (Basel, Switzerland), 13(11), 354. https://doi.org/10.3390/diseases13110354 

D’Aiuto, F., Suvan, J., Siripaiboonpong, N., Gatzoulis, M. A., & D’Aiuto, F. (2025). The root of the matter: Linking oral health to chronic diseases prevention. International Journal of Cardiology Congenital Heart Disease, 19, 100574. https://doi.org/10.1016/j.ijcchd.2025.100574 

Centers for Disease Control and Prevention. (n.d.-b). Preventing oral diseases and conditions in communities. Centers for Disease Control and Prevention. https://www.cdc.gov/oral-health/prevention/index.html 

World Health Organization. (n.d.). Oral Health. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/oral-health 

U.S. Department of Health and Human Services. (n.d.). Oral Hygiene. National Institute of Dental and Craniofacial Research. https://www.nidcr.nih.gov/health-info/oral-hygiene 

James Myhre & Dennis Sifris, M. (n.d.). The hard facts about fluoride toothpaste. Verywell Health. https://www.verywellhealth.com/facts-about-fluoride-toothpaste-4587999 

Please also review AIHCP’s Case Management Certification program and see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Harry Wolf,

For healthcare professionals who are aiming to build trust and credibility with patients (which is, surely, all healthcare professionals), a strong digital presence is of the utmost importance.

Thoughtful online strategies will help you stand out – and showcase your expertise and professionalism. 

Keep Your Online Bio Accurate – and Up-to-Date

To decide if a healthcare provider is trustworthy, patients often rely on reviewing online bios. An outdated bio creates doubts. It signals a lack of attention or professionalism. Conversely, keeping your information current reflects your commitment to accuracy and builds immediate trust.

Review your bio often. Are all roles, credentials, and affiliations updated? Remove any irrelevant details that clutter the narrative. And use concise language focused on the qualifications that patients care about most.

To strengthen your credibility:

• Include recent certifications.
• Highlight clinical specialties that are relevant to patient needs.
• Add professional memberships or recognitions where appropriate.

A well-maintained bio reassures patients they are choosing someone who is actively engaged in their profession. It helps them feel confident that you bring expertise shaped by ongoing experience. This small effort goes far in fostering trust from the offset.

Showcase Relevant Certifications – and Continuing Education

Following on from the last section, certifications and ongoing education demonstrate your commitment to staying informed about advancements in the industry of healthcare. Patients want assurance that their provider remains current with the latest practices. 

Highlighting these qualifications online solidifies trust in your expertise. Display certifications prominently on professional platforms, practice websites, or directories where patients may search for providers. Make sure the information is easy to verify if necessary—list accrediting organizations or institutions by name, for instance.

To maximize impact:

• Update certifications as they are renewed or newly earned.
• Include any specialized training.
• Mention conferences/workshops/continuing education programs you have attended recently.

When patients see evidence of recent learning efforts, it’ll signal that you take their care seriously enough to invest time in improving your skills.  This transparency makes them feel confident that they are receiving advice backed by up-to-date expertise.

Highlight Patient Outcomes with Measurable Results

Patients trust providers who demonstrate real/tangible results. Hence, highlighting patient outcomes helps prospective patients to understand the quality of care that you deliver – and sets realistic expectations. This strategy can significantly enhance your credibility – when done ethically and thoughtfully, that is. Focus on presenting measurable outcomes that align with your specialty or expertise. And avoid vague claims.

Here are some examples of what to share:

• Post-surgery recovery rates (if applicable) or success stories (with consent).
• Statistics showing improved patient health under your care.
• Positive feedback reflecting specific areas of excellence in treatment.

Present these insights visually – if possible. Charts or simple graphics are easy to digest. 

By showcasing proven successes, you will reassure potential patients that they’ll benefit from evidence-based practices.

Create a Consistent Professional Image Across Platforms

An inconsistent or unprofessional image can create confusion. In turn, it can reduce trust.  A cohesive digital presence signals: reliability and attention to detail. Use professional photos and ensure your profile details align on all platforms – whether it’s your practice website, LinkedIn, or medical directories.  Inconsistent titles, incomplete bios, or mismatched imagery may raise red flags for patients who are seeking trustworthy care (which is, of course, every patient!).

To maintain consistency:

• Use the same professionally taken headshot across profiles.
• Ensure your credentials are listed identically on all platforms.
• Align the tone and language with your targeted audience.

This uniformity reflects not just who you are but also how seriously you take patient relationships. 

A seamless online identity creates an impression of dependability – before patients even set foot in your office.

Use Testimonials and Reviews – to Build Credibility

Don’t overlook the immense power of testimonials. According to 2025 data published by WiserReview, 72% of customers trust businesses more after reading positive testimonials and reviews. And around 92% of consumers read testimonials and reviews before making purchases.

When choosing a healthcare provider, patients trust the experiences of others. Testimonials and reviews act as social proof – offering reassurance about your:

• Professionalism.
• Expertise.
• Ability to deliver positive outcomes.

So, request feedback from satisfied patients (as long as they feel comfortable sharing their stories, that is). Make sure those testimonials highlight specific aspects of your care that resonate with prospective patients.

Best practices for leveraging reviews? They are as follows:

• Display verified patient testimonials on your website prominently.
• Respond professionally to online reviews.
• Highlight patterns in feedback that showcase your strengths.

When done thoughtfully and ethically, using real voices amplifies trust in ways no self-written description can achieve. 

Prospective patients will gain confidence by knowing others in your care had meaningful success.

Maintain Active Engagement on Professional Networks 

Professional networks are valuable for showcasing your expertise and building trust with both patients and colleagues. An inactive or sparse profile can appear uninvested. But consistent activity highlights your dedication to staying engaged in the healthcare field.

Use platforms like LinkedIn to:

• Share updates about your work.
• Comment on industry news.
• Celebrate those all-important milestones of yours. 

This visibility helps patients see you as an informed professional who is committed to advancing in your specialty.

Key actions for active engagement? They include these:

• Share articles or research that reflect current trends in healthcare.
• Post thoughtful insights from conferences you attend.
• Engage with other professionals.

By maintaining a strong presence online, you will show potential patients that you are not just practicing – but actively participating in improving the field of medicine. This reinforces credibility and creates opportunities.

Publish Informative Content – That Reflects Your Expertise

To establish yourself as a trusted authority in your field, create and share informative content.

Providing this shows you’re:

• Knowledgeable.
• Approachable.
• Committed to educating others.

Write articles or blog posts on topics that align with patient interests. 

You could also share educational videos or infographics – for a more engaging approach. Infographics are a particularly effective way for prospective clients to consume content, due to their visual appeal and their ability to make complex information easy to digest. However, as a Forbes article points out: “(An infographic is only) effective if its content and context are aligned to reach the target audience and deliver the knowledge they need and want.”

To craft impactful content (in general):

• Focus on relevant subjects like managing chronic conditions or explaining treatment options.
• Use simple language – but avoid oversimplification of complex medical ideas.
• Ensure all information is accurate/well-researched/cited.

This strategy not only builds trust – but also keeps patients coming back to your platforms for guidance. 

It demonstrates that you are invested in improving understanding around healthcare issues.

Adopt Transparent Communication Practices – on Your Website and Social Media Channels

Clear and honest communication builds trust. Patients want to feel informed about their provider’s approach/services/values before they make decisions. By being transparent online, you eliminate uncertainties that could cause hesitation. Use your website or social media platforms to outline key aspects of your practice. Be upfront about the services offered, pricing (where applicable), or what patients can expect during visits.

Here are some ways to improve transparency:

• Share step-by-step explanations of procedures or treatment processes.
• Include FAQs.
• Use plain language (rather than medical jargon, that is).

Transparency reassures patients. And it prioritizes open relationships right from the beginning. When individuals see clear answers upfront, it instills confidence in your professionalism and reduces potential barriers to reaching out for care.

Focus on Building Trust Through Privacy Assurance Measures Online

Patients need to trust that their information is safe. Demonstrating strong privacy practices online reassures your patients that you take data security seriously. Clearly communicate your commitment to protecting patient confidentiality. Highlight compliance with regulations like HIPAA (in the U.S.) or similar laws elsewhere, as this showcases professionalism and reliability. Steps for ensuring privacy assurance? 

• Display clear privacy policies on your website.
• Use secure contact forms – for appointment requests or inquiries.
• Avoid sharing any identifiable patient stories or images without explicit consent.

By prioritizing transparency around how sensitive information is managed, you show respect for patients’ rights and their concerns about digital safety—further solidifying trust in your care delivery approach before they even meet you in person.

Invest in High-Quality, Professionally-taken Photographs

A professional photo is of crucial importance – for establishing trust and credibility, that is. Patients connect better when they see a provider who looks:

• Confident.
• Approachable.
• Professional. 

Conversely, poor-quality images – or inconsistent visuals – can unintentionally send the wrong message. Professionally taken photos—such as doctor headshots—can set you apart online. They show that you care about details and take your role seriously.  These images should align with the tone of your practice – whilst making patients feel at ease.

Here are some helpful tips for effective headshots:

• Dress professionally in attire that reflects your role (but without being overly formal!).
• Use well-lit settings with simple backgrounds.
• Ensure consistency – by using the same image across all platforms.

Investing in this step builds immediate trustworthiness!

The Takeaway

By presenting yourself authentically, transparently, and consistently, you will create lasting connections that strengthen both your practice and patient relationships.

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References:

Meier, Michelle. Grow your practice with a great healthcare professional bio (with example). The Intake, Tebra. https://www.tebra.com/theintake/practice-growth/get-new-patients/grow-practice-healthcare-professional-bio

Unauthored. The Importance of Continuing Education in the Healthcare Industry. Portobello Institute.

https://blog.portobelloinstitute.com/the-importance-of-continuing-education-in-the-healthcare-industry

Fernandez, Amandine. The cost of an inconsistent visual identity. Letsignit. https://letsignit.com/blog/cost-of-an-inconsistent-visual-identity

Vaghasiya, Krunal. 12 Must-know testimonial statistics (2025 Data). WiserReview. https://wiserreview.com/blog/testimonial-statistics/

Forbes Councils Member, Expert Panel®. 12 Effective Ways To Use Infographics For Marketing. Forbes. https://www.forbes.com/councils/forbesagencycouncil/2021/01/25/12-effective-ways-to-use-infographics-for-marketing/

Written by Veronica Turner.

Not too long ago, the idea that doctors had to wash their hands in between patients was absurd. It took trailblazers such as Ignaz Semmelweis to realize the existence of germs and understand the effects of pathogens. Thanks to them, hygiene, which includes thorough handwashing, is now a fundamental, non-negotiable standard for healthcare providers worldwide.

Modern healthcare units today have well-established cleaning procedures whose efficacy is reviewed periodically by accrediting organizations (like The Joint Commission) and enforced by regulators like the Centers for Medicare & Medicaid Services (CMS).

Such organizations use adherence to these protocols and infection prevention outcomes as key factors in their scoring systems. This means that, besides patient safety, a lapse in environmental hygiene can affect an organization’s financial health and accreditation status. 

In this article, we investigate how scientific evidence connects environmental cleaning to infection prevention, how monitoring systems enhance compliance, and the way in which these activities have a direct effect on accreditation metrics and reimbursement models.

Cleaning Protocols and Patient Safety

There is overwhelming evidence of the association between environmental cleaning and patient safety in the literature. Studies have confirmed that high-touch surfaces, such as sink and nurse call buttons, can be a source of pathogens such as Clostridioides difficile (C. difficile), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococcus (VRE).

Without proper cleaning protocols, only about 48% of high-touch surfaces situated near patients are cleaned correctly, according to a multi-hospital study. This shows that gaps in routine protocols directly contribute to pathogen persistence and the risk of onward transmission. It’s also the reason why healthcare-associated infections (HAIs) are one of the greatest hospital and long-term care facility risks and a factor leading to increased hospitalizations, increased cost of treatment, and additional mortality.

The Results of Proper Cleaning Protocols

Based on results from randomized controlled trials, we know that comprehensive cleaning schemes can prevent infection. A comprehensive cleaning scheme usually combines the latest disinfectant strategies, advanced technologies, and proper training to kill a broad spectrum of pathogens on various surfaces.

For example, in a trial (the BETR study), rooms that were cleaned using ultraviolet-C (UV-C) adjunct disinfection were associated with a 11% decrease in patient acquisition of target organisms. That meant fewer C. difficile and VRE infections hospitalwide. Additional clinical studies support that thorough terminal cleaning, especially in rooms previously housing infected patients, can reduce surface contamination by approximately 99%.

Many healthcare workers and even patients still remember the recent COVID-19 outbreak and the chaos it ensued. It was also a time for patients and healthcare workers to understand just how important cleaning can be. Sadly, the lack of well-established cleaning standards and monitoring systems led to numerous avoidable deaths.

Cleaning Protocols and Their Impact on Accreditation Metrics

Healthcare units everywhere should consider the existence and implementation of proper cleaning protocols as a part of their standard of care. In the U.S, organizations are somewhat forced to do this because their procedures are in plain view and open to scrutiny.

All patients have the right to fill in a standardized patient satisfaction survey after they’ve been treated in a hospital or clinic. The most important ones (that are also reported to authorities) are: 

• HCAHPS (Hospital Consumer Assessment of Healthcare Providers and Systems): available at the national level, and collects information on what patients think of the care they received during treatment.
• CAHPS (Consumer Assessment of Healthcare Providers and Systems): a collection of surveys that allow patients to grade their experience in different healthcare scenarios, like hospitals, home healthcare, and specialty providers.

In addition to patient surveys, U.S. healthcare organizations are judged based on the Hospital-Acquired Infection (HAI) rates. The HAI rate represents the frequency with which patients develop an infection while receiving care for another condition. This infection must not be present in the patient or incubating at the time of admission. High HAI rates signal a problem with the quality and safety of care in that unit.

In short, cleaning protocols are a direct and effective method for improving patient outcomes and boosting a unit’s accreditation and safety ratings.

The Role of Monitoring and Auditing

Healthcare units need consistent monitoring to maintain effective cleaning practices. U.S. hospital data demonstrate that audit-and-feedback programs can increase cleaning effectiveness from less than half of surfaces cleaned (~47%) to more than 80% within months. 

Monitoring also encourages behavioral changes in hospital or clinic staff. When it’s clear that the organization keeps track of cleaning performance and brings up the topic during staff training, you create accountability mechanisms that are hard to ignore.

The methods used also have an impact on efficiency. Medical cleaning personnel are more likely to use easy-to-implement interventions that provide accurate, immediate feedback, such as fluorescent gel markers and adenosine triphosphate (ATP).

For example, fluorescent gel is the go-to in many units because of its ease of use. Cleaning services staff apply the gel to surfaces before cleaning, then shine a UV light on the surface to check for any glowing residue. If it glows, the surface is not entirely clean or thoroughly disinfected. 

The Financial Impact of Accreditation Metrics

Due to rules established by accredited bodies, there is a direct connection between Hospital-Acquired Condition (HAC) rates and institutional performance, accreditation, and reimbursement structures. This is also a way to encourage healthcare organizations to prioritize the safety of their patients and staff.

For example, the CMS established the HAC Reduction Program, which penalizes hospitals that fall into the worst-performing quartile based on their Total HAC Score. These organizations face a 1% reduction in Medicare payments. It may not sound like much, but it can amount to millions of dollars for large organizations. 

Another regulating body is the Joint Commission International (JCI), which evaluates and accredits more than 20,000 healthcare organizations in the United States and internationally. This agency considers infection control and cleaning protocols when evaluating performance.

The JCI “Gold Seal of Approval” is a strong indicator that a hospital or clinic is committed to patient safety and best practices. If an on-site inspection finds deficiencies in environmental cleaning, that organization could lose accreditation and face public scrutiny. 

Lastly, hospital-acquired conditions themselves are a financial burden, costing hospitals and clinics billions every year. Meanwhile, the cost of housekeeping and environmental services is between 3 and 6 million per hospital per year, on average (excluding extremely specialized infection control beyond normal protocols). 

In short, it’s more affordable to have proper cleaning protocols than to take shortcuts and gamble your patients’ safety and the organization’s reputation and accreditation.

How to Operationalize High-Quality Cleaning Protocols

Well-designed, high-quality cleaning protocols use a strategic, multifaceted approach that integrates staff training, modern technology, and a commitment to quality assurance.

Staff Training and Competency

Every healthcare unit needs an on-site environmental services team. These professionals are the first line of defense against HAIs and HACs and a cornerstone of a safe patient environment.

They must be well-trained in basic areas such as:

• Scientific Principles: how pathogens are transmitted and why specific disinfectants are effective against certain microbes.
• Protocol Adherence: Detailed, hands-on instruction on proper cleaning techniques for different surfaces and areas, including the correct sequence of cleaning to avoid cross-contamination.
• Safety and PPE: Proper use of Personal Protective Equipment (PPE) to protect both the worker and the patient.

Each healthcare unit must have a regular training schedule (e.g., once every three months) and a competency assessment system to ensure that staff maintain their skills and stay current with new best practices. Cleaning protocol training is not a one-and-done kind of thing. 

Technology and Innovation

Technology can make cleaning protocols more effective and efficient while reducing human error. It also makes the job safer and easier for cleaning staff, benefiting everyone involved in the process.

Here are a few examples of how modern technologies transform medical cleaning:

• UV-C light disinfection (UV-C robots): These are automated systems that use ultraviolet light to destroy the DNA of germs, rendering them unable to replicate. They’re fast and can disinfect entire rooms, including hard-to-reach areas, in minutes.
• Electrostatic Sprayers: This technology applies a positive charge to disinfectant droplets, causing them to cling to negatively charged surfaces. This ensures a more even and thorough coverage of complex and irregularly shaped objects like bed rails and medical equipment.
• Monitoring and Verification Systems: As discussed earlier, systems like adenosine triphosphate (ATP) testing and fluorescent markers provide objective, data-driven feedback on cleaning effectiveness.

Commercial Cleaning Services

Healthcare organizations tend to partner with specialized providers of healthcare facilities cleaning, even if there’s an in-house team that handles routine daily tasks. Commercial services can provide access to a highly trained workforce, advanced technology, expertise in complex regulatory standards, and additional labor for specific needs.

For example, after a patient with an infectious disease is discharged, a commercial service can perform a deep, comprehensive terminal clean using advanced techniques and equipment to ensure the room is completely decontaminated.

Commercial services are also trained and certified to handle the cleanup and disposal of biohazardous materials, a task that requires specific protocols and a high level of expertise. 

In Conclusion

As we’ve proven, cleaning protocols are central to patient safety, accreditation, and financial sustainability. Evidence shows that thorough, audited cleaning reduces infections, protects vulnerable patients, and safeguards hospitals from penalties and reputational damage. 

Author Bio: Veronica Turner is a health and lifestyle writer with over 10 years of experience. She creates compelling content on nutrition, fitness, mental health, and overall wellness.

References

Weber, David J. et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species, American Journal of Infection Control, Volume 38, Issue 5, S25 – S33, https://www.ajicjournal.org/article/S0196-6553(10)00408-6/fulltext 

Verhougstraete, M., Cooksey, E., Walker, J., Wilson, A. M., Lewis, M. S., Yoder, A., Elizondo-Craig, G., Almoslem, M., Forysiak, E., & Weir, M. H. (2024). Impact of terminal cleaning in rooms previously occupied by patients with healthcare-associated infections. PLoS ONE, 19(7), e0305083. https://doi.org/10.1371/journal.pone.0305083 

Carling, P. C., Parry, M. M., Rupp, M. E., Po, J. L., Dick, B., & Von Beheren, S. (2008). Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infection Control and Hospital Epidemiology, 29(11), 1035–1041. https://doi.org/10.1086/591940 

Anderson, D. J., Moehring, R. W., Weber, D. J., Lewis, S. S., Chen, L. F., Schwab, J. C., Becherer, P., Blocker, M., Triplett, P. F., Knelson, L. P., Lokhnygina, Y., Rutala, W. A., Sexton, D. J., & CDC Prevention Epicenters Program (2018). Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection). The Lancet. Infectious diseases, 18(8), 845–853. https://doi.org/10.1016/S1473-3099(18)30278-0 

Izadi, N., Etemad, K., Mehrabi, Y., Eshrati, B., & Hashemi Nazari, S. S. (2021). The Standardization of Hospital-Acquired Infection Rates Using Prediction Models in Iran: Observational Study of National Nosocomial Infection Registry Data. JMIR public health and surveillance, 7(12), e33296. https://doi.org/10.2196/33296 

Centers for Medicare & Medicaid Services (2025). Hospital-Acquired Condition (HAC) Reduction Program: Scoring Methodology. ttps://www.cms.gov/files/document/fy-2026-hac-reduction-program-methodology-infographic-updated-08/04/2025.pdf 

Haag, C., Archulet, K., RN, & Chau, A. (2024, November 7). Closing the gap: Maximizing the potential of UV-C technology to reduce Health Care-Associated infections. Infection Control Today. https://www.infectioncontroltoday.com/view/closing-gap-maximizing-potential-uv-c-technology-reduce-health-care-associated-infections 

Environmental cleaning procedures. (2024, March 19). Healthcare-Associated Infections (HAIs). https://www.cdc.gov/healthcare-associated-infections/hcp/cleaning-global/procedures.html 

Gastaldi, S. et al. (2025). Tools and strategies for monitoring hospital environmental hygiene services. Journal of Hospital Infection, Volume 159, 52 – 61. https://doi.org/10.1016/j.jhin.2025.01.011. 

Please also review AIHCP’s Certification programs and see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification